Key Takeaways
- Cerebras (CBRS) shares advanced +6.5% during morning hours on June 10, hitting $241.63, fueled by ongoing analyst coverage launches.
- On June 9, Craig-Hallum started coverage with a Buy recommendation and $325 target, highlighting the company’s wafer-scale architecture as the leading AI inference platform.
- More than nine Wall Street firms—Citi, Morgan Stanley, Wedbush, UBS, and others—unveiled coverage with positive ratings and targets spanning $250 to $340.
- During SuperAI Singapore 2026, Cerebras’s Chief Strategy Officer showcased live performance comparisons where the Wafer Scale Engine outpaced Nvidia’s B200 in real-world AI applications before approximately 10,000 conference participants.
- The company will report its inaugural public quarterly results on June 23, with analyst consensus pointing to a $294 price target—representing approximately 26.7% potential upside.
Shares of Cerebras Systems (CBRS) advanced 6.5% during morning hours on June 10, touching $241.63, bucking the broader market’s downward trend. The S&P 500 declined 0.8%, while the Dow Jones Industrial Average retreated 1.0%, and the Nasdaq Composite fell 1.1% during the same session.
The upward momentum followed Craig-Hallum’s coverage launch on June 9, which featured a Buy recommendation accompanied by a $325 price objective. The firm highlighted Cerebras’s proprietary wafer-scale computing architecture as the market’s premier AI inference platform.
This initiation represented the most recent addition to a series of optimistic assessments that commenced following the conclusion of Cerebras’s post-IPO quiet period on June 8. Over nine prominent Wall Street institutions—including Citi, Morgan Stanley, Wedbush, Rosenblatt, Needham, Mizuho, Barclays, TD Cowen, and UBS—all unveiled coverage featuring Buy-equivalent ratings. Price objectives across these initiations spanned from $250 to $340.
The company debuted publicly at $185 per share. After touching a 52-week peak of $386.34, the stock experienced a notable pullback and now appears to be garnering renewed institutional attention as Wall Street firms establish formal research positions.
A recurring theme throughout analyst assessments centers on Cerebras’s competitive advantage in rapid inference—executing AI models in real-time applications. Two significant partnerships underpin this narrative: both OpenAI and Amazon designated Cerebras as their inference platform of choice within the last six months.
OpenAI has committed to 750 megawatts of data-center infrastructure planned for Cerebras deployment across multiple years. Amazon’s AWS will integrate Cerebras technology natively through a hybrid inference configuration, utilizing Trainium for the prefill phase while Cerebras handles the accelerated decode phase.
The Technology Behind the Wafer Scale Engine
The Cerebras Wafer Scale Engine surpasses conventional processors by more than 50 times in physical size. It incorporates 900,000 AI-optimized cores while maintaining tight integration of compute, memory, and communication pathways on a single expansive silicon substrate.
Chief Strategy Officer Andy Hock presented this technology publicly at SuperAI Singapore 2026, physically displaying the chip before approximately 10,000 conference participants while conducting direct comparisons with Nvidia’s B200 platform.
Hock conducted live demonstrations utilizing Meta’s Llama 4 Maverick model, where Cerebras completed tasks—such as generating a Tetris game in Python and constructing a two-week road trip itinerary—before GPU-based systems concluded processing.
His central thesis: AI reasoning models can demand approximately 100 times greater computational resources than standard queries, while agentic AI workflows may require 1,000 times more processing power. This dynamic transforms raw processing speed from a competitive advantage into a fundamental necessity.
Inaugural Earnings Report Approaching
Cerebras announced it will unveil its first quarterly financial results as a publicly traded entity on June 23. This upcoming milestone provides an additional near-term catalyst for market participants monitoring the stock.
Wall Street currently maintains a Strong Buy consensus rating on CBRS, supported by 10 Buy ratings issued across the past three months. The average analyst price objective stands at $294, suggesting approximately 26.7% upside potential from present trading levels.


